Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025

Research Article: Cyclophosphamıde–Etoposıde + G-csf Compared to G-csf alone in Perıpheral Blood Stem Cell Mobılızatıon for Multıple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAysun Halaçoğlu

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows improved CD34 counts and faster engraftment in multiple myeloma patients using Cyclophosphamide-Etoposide and G-CSF.

Key Points

  • Cyclophosphamide and G-CSF increased CD34 cell counts significantly compared to G-CSF alone.
  • Patients underwent fewer apheresis sessions with Cyclophosphamide-Etoposide, enhancing stem cell mobilization.
  • Time to neutrophil and platelet engraftment was shorter in the Cyclophosphamide-Etoposide group, indicating better recovery.
  • Overall, Cyclophosphamide-Etoposide improved outcomes in stem cell mobilization for multiple myeloma patients.

Cite This Study

Aysun Halaçoğlu (2022) studied this question.

synapsesocial.com/papers/68c1e30154b1d3bfb6100451https://doi.org/10.31579/2835-9259/002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Etoposide + cytarabine + pegfilgrastim vs cyclophosphamide + granulocyte colony-stimulating factor for stem-cell mobilization in patients with multiple myeloma: A phase III trial2025
  2. 2Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: <scp>CE</scp> plus <scp>G‐CSF</scp> versus <scp>G‐CSF</scp> only: A single‐center retrospective analysis2024 · 8 citations
  3. 3A randomized comparison of etoposide and cyclophosphamide for stem cell mobilization in newly diagnosed multiple myeloma2026
  4. 4[Comparison of etoposide combined with G-CSF and cyclophosphamide combined with G-CSF in the mobilization of autologous peripheral blood stem cells in patients with multiple myeloma].2024 · 1 citations
  5. 5Intermediate-High-Dose Cyclophosphamide for Stem Cell Mobilization in Lymphoma: A Single-Center Retrospective Study2025